UNICYCIVE THERAPEUTICS, INC. Operating Lease Liability
UNICYCIVE THERAPEUTICS, INC. (UNCY) had Operating Lease Liability of $671.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability $671.00K.
- 2026-03-31: Operating Lease, Liability $815.00K.
- 2025-12-31: Operating Lease, Liability $117.00K.
- 2025-09-30: Operating Lease, Liability $265.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $671.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $815.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $117.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $265.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $409.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $548.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $681.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $807.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $634.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $715.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $793.00K 10-K · filed 2024-03-28 |
| 2023-03-15 | $1.00M 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |